To assess the multiple risk factors reported to be associated with onset of serious bacterial, fungal, viral, and protozoal infections in renal allograft recipients, a retrospective study of all renal transplantations performed at Yale-New Haven Medical Center from the inception of the transplantation program in December, 1967, to December, 1975 Ninety-six renal allograft transplants in 85 patients were available for evaluation during this study period. Renal allograft recipients were evaluated for incidence of infection from time of transplantation until transplant nephrectomy, death, or January 1, 1976. All infections were characterized by type of infection, organism, site, and time of onset post-transplantation. Recipients with infections were also evaluated for their donor type, living-related or cadaveric, age at time of transplantation, granulocytopenia, corticosteroid therapy, and rejection episodes.
INTRODUCTION
Serious bacterial, fungal, viral, and protozoan infections comprise the welldocumented causes of morbidity and mortality in the immunosuppressed patient population [1] [2] [3] . Risk factors which predispose renal allograft recipients to their infections have been suggested, but no unifying hypothesis has been established [4] [5] [6] [7] [8] [9] . The present study, therefore, was undertaken to assess multiple risk factors through a retrospective evaluation of all renal transplantations performed at Yale-New Haven Medical Center from the inception of the program in December, 1967 , until December, 1975 . In particular, potential temporal relationships between episodes of granulocytopenia, allograft rejection, and infection were evaluated. 
MATERIALS AND METHODS

Population
One hundred and forty-eight renal allograft transplantations were performed in 135 patients at Yale-New Haven Medical Center between December, 1967, and December, 1975 . Thirty of the 148 renal transplants were performed on 29 patients in the West Haven Veterans Administration Hospital and were not evaluated in the present study. Also, the infectious complications in 21 patients with 22 of the remaining 118 renal allografts could not be properly evaluated since documentation of particular findings needed for the diagnosis of the infection (see definitions) was not available in the hospital record or the post-transplant flow sheet. Therefore, 96 renal allografts performed in 85 patients were available for evaluation and comprise the patient population of this retrospective study. All charts were evaluated from the time of transplantation until removal of the transplanted kidney, death, or January 1, 1976 , whichever occurred first.
Retrieval of Data
All data was retrieved according to the methods described by Feinstein for retrospective chart analysis [10, 11] . Thus, cases were excluded from analyses of incidences of particular findings if the presence or absence of these findings were not clearly documented. Therefore, the data presented represent the number of cases of renal allograft recipients with positive findings in relationship to the number of cases when verifications of positive or negative findings could be made.
The data on each transplant recipient were obtained from two sources: the hospital record and the immediate post-transplant flow sheets maintained by the renal section. The following data were obtained for all patients: sex, age, and weight at time of transplant, race, type of renal disease, donor type (cadaver or living related), and date of transplant operation. In addition, white blood cell count with percent polymorphonuclear leucocytes, blood urea nitrogen, creatinine, dosages of corticosteroids, azothioprine, actinomycin D, and anti-lymphocytic globulin (ALG), as well as all diagnostic procedures including microbiology studies, chest roentgenograms, renal scans, and biopsies were also evaluated.
All infectious complications which occurred during each post-transplant hospitalization were documented as to etiology, site, and clinical course. Infections were classified by the following criteria:
Symptomatic urinary tract infection. A single clean catch or catheter urine specimen containing greater than 100,000 colonies per milliliter bacteria, in association with clinical signs of infection which included fever, dysuria, urgency, and frequency.
Lower respiratory tract infection. Patients with any four of the following six criteria were classified as having lower respiratory tract infection: (1) Relative granulocytopenia. A polymorphonuclear leucocyte cell count greater than 1000 and less than or equal to 2000 cell/mm3 blood on two sequential differential white blood cell counts was considered to be relative granulocytopenia.
Granulocytopenia. Granulocytopenia was defined as a polymorphonuclear leucocyte cell count of less than 2000 cells/mm.3 This included both severe and relative granulocytopenia.
Corticosteroid therapy. High dose corticosteroid therapy was defined as a steroid dose equivalent to one or more milligrams per kilogram per day of prednisone for 27 of the first 60 days after transplantation. This definition was chosen since, as noted by Finkelstein and Black [7] in their analysis of a segment of this population, one episode of acute rejection, to which the patient responded successfully, usually involved high dose (1 mg/ kg prednisone) corticosteroid therapy for 26 or fewer days within the first 60 days.
Age and allograft. Patients' age at time of transplantation, and type of allograft, i.e., cadaver, or living-related, were also correlated with incidence of infection.
Data Analysis
The incidence of infection was based on the observation of the number of times a particular infection occurred divided by the total number of renal allograft recipients (96 renal allografts). Mortality data is calculated from the total number of patients in the analysis (85 patients). Statistical significance was determined by chi square analysis using Yates correction factor for small numbers [12] .
RESULTS
Population
In this study population, 96 renal allografts were performed in 85 patients, eleven of whom received two renal allografts. There were 21 living-related donors and 75 cadaveric donors. Patients ranged in age between one and 56 years. There were 51 males and 34 females. Eight males and three females received two renal allografts. The population included 61 Caucasians, 20 Blacks, two Hispanic and two Asian patients.
Primary renal diseases included 31 patients with chronic glomerulonephritis, 7 patients with malignant hypertension, 5 patients with chronic pyelonephritis, 5 patients with interstitial nephritis, and 2 patients each with systemic lupus erythematosis, diabetic nephropathy, Wegener's granulomatosis, obstructive uropathy, and hereditary medullary cystic disease. Single cases of uric acid nephrocalcinosis, rapidly progressive glomerulonephritis, renal cell carcinoma, and congenital multicystic disease were also reported. In 20 patients, the primary renal disease was not known.
Infections
Two hundred and fifteen infections were documented in 78 of the 96 renal allografts. Of the 215 infections, 92 were considered to be serious as previously defined. These occurred in 45 of the 78 allografts who had some type of infection, whereas 33 of these 78 recipients had non-serious infections and 18 renal allograft recipients (17 patients) had no infection throughout their course. Figure 1 demonstrates that in every age group there was a higher percentage of serious infections in patients with cadaveric donors. In addition, patients with cadaveric kidneys under the age of 10 and over 40 had a greater percentage of infections compared with cadaveric recipients between the ages of 10 and 40. Although this finding is not statistically significant (0.1 < p < 0.2), the numbers of patients less than 10 years and greater than 40 years of age were small. The urinary tract was the most common site of infection in our population of renal allograft recipients. However, among the serious infections, septicemia and lower respiratory tract infection were most frequent, with 34 respiratory tract infections and 28 episodes of septicemia documented. Other serious infections included hepatitis in 4 patients, meningitis in 3 patients and pericarditis and efidocarditis in one patient each (Table 1 ). There were five episodes of unexplained fever and 7 of asymptomatic bacteriuria.
The etiology of these infections is shown in 
Infections-Rejections
The time of all documented infections and rejections in the post-transplant period is shown in Fig. 3 . The highest incidence of both infections and rejections occurred within the first sixty days after transplantation. However, after the first posttransplantation year transplant rejection became a relatively minor contribution to morbidity, whereas late onset infection persisted and was a major factor in the morbidity and mortality, i.e., 48% of the surviving recipients in this study experienced a documented infection after one year while only 7% had a rejection episode.
Two of the 96 recipients experienced a severe rejection episode within the first 72 hours and underwent transplant nephrectomies. In the remaining 94 recipients the number of serious infections were compared between 73 recipients with two or less rejection episodes and 21 recipients with three or more rejection episodes during their clinical course. Twenty-nine of the 73 recipients with two or fewer rejection episodes had 65 serious infections (2.2 infections per patient) while 12 of 21 recipients with three or more rejection episodes had 31 serious infections (2.6 infections per patient). The differences between the two groups was not statistically significant (p 2 0.20).
Infection-granulocytopenia. Seven of the 94 evaluable recipients had episodes of severe granulocytopenia (granulocytes < 1000/mm3) and 13 recipients had an Table 2 are not included in this figure thus the total number of infections does not equal 215. Number in parenthesis indicate the actual number of infections in the 78 renal allograft recipients at each site. episode of relative granulocytopenia (granulocytes > 1000 < 2000/mm3) (Fig. 4) The incidence of serious infection in severe granulocytopenic recipients compared with the non-gra-nulocytopenic group was not significant (0.10 > p < 0.20). This may be related to the small number of allograft recipients in the severe granulocytopenic group, since the incidence of serious infection in the relative granulocytopenic recipients compared with the non-granulocytopenic group was significant (p < 0.01), as was the incidence when both severe and relative granulocytopenic groups were combined and compared with the non-granulocytopenic group. There was no significant difference in the number of serious infections between the severe and relative granulocytopenic groups. (15) ) (6) (T)
(30) (6) (4) [7] . The overall mortality rate in our series was 33% and approximately the mortality rate found by Anderson et al. [4] and Gurland et al. [14] though it is higher than a recently reported series from Belfast [13] .
In an attempt to isolate specific potential risk factors in the present study each transplant recipient was evaluated according to stricter definitions of leukopenia and infection than have been employed in previous studies by others. Prolonged high [8, 15, 16] . In general the most common early postoperative infections were from the urinary tract and these represented 29% of the 215 infections in the series. What we defined as serious infections represented 42% of all infections (92/215). In this group there was a 30%o incidence of sepsis and a 34% incidence of pneumonia. Thus, like Turcotte [16] , we found pneumonia to be a common event associated with a high mortality rate. Gramnegative bacteria were the most common pathogens in these infections.
As others have reported, we found a correlation between granulocytopenia and serious infections. Anderson et al. [14] , using a rather broader definition of leukopenia (total white blood cells of less than 3000/mm3 for a minimum of three consecutive determinations on different days) were unable to demonstrate a significant temporal association between episodes of infection and episodes of granulocytopenia. In a smaller study, Simmons et al., using an equally broad definition, observed 18 episodes of leukopenia in a group of 9 patients with a correlation noted in 13 infections [5] . A further restriction of this study, however, was a minimal survivor time of all 98 patients of at least 250 days from transplantation. With regard to evaluating leukopenia further as a risk factor we chose parameters that took into account Bodey's and his co-workers correlation between increased incidence of infection and granulocyte count <1000/mm3 [17] . In our series 20 allograft recipients had 32 granulocytopenic episodes that could be divided into severe granulocytopenia <1000/ mm3 and relative granulocytopenia (1000-2000 mm3). Using these -more restrictive criteria, we found that onlv 8 of thcse 32 neutropenic episodes were temporally associated with serious infectioni. IThese observations fail to inidicalte a temnporal association between severe granulocytopenia and infection alone, even though these 20 allograft recipients in the study with one or more episode of granulocytopenia did have a higher incidence of scerious infection thaln those recipienits who were never granulocytopenic in thcir clinical course (p < 0.01).
The observation that rejection predisposes to infection through alteration in humoral immunity and in some cases through rejection-mediated leukopenia or following vigorous anti-rejection therapy is frequently stated in the literature [4, [18] [19] [20] . In an attempt to document this relationship in our series, the incidence of infection in 21 renal allograft recipients who had three or more rejection episodes at any time in their clinical course was compared with the incidence of infection in the 73 recipients who experienced two or fewer rejections. No statistical significance was found between these groups. However, in a prior study of this patient population, Finkelstein et al. [7] had reported that a second rejection episode within the first two months post-transplantation predisposes to increased mortality. These authors report 9 deaths or transplant nephrectomies in 12 patients with greater than two rejections while only 9 of 27 patients with no rejections died or underwent transplant nephrectomy. This data is at variance with the Belfast series, which had a lower rejection rate overall, and no deaths caused by infection within the first 60 days after transplantation. There were, however, two later deaths caused by infections which were associated with leucopenia brought about by anti-rejection therapy [13] . Nonetheless, our data appears comparable with the general experience reported in this country and Europe with approximately a 35% mortality rate associated with serious infections [4, 14] . With alteration in the approach to immunosuppressive therapy there have been conflicting and changing data on the role of high dose steroids as a putative risk factor. The 39 allograft recipients we were able to evaluate represented a population too small to be evaluated statistically. However, in the present series, recipients treated with high dose steroids did have a higher mortality rate (33%) secondary to infection than the low dose group (I 1%).
In conclusion, analysis of our renal allograft recipient population did not establish significant temporal relationships between the potential risk factors, leucopenia, multiple rejection episodes, high dose corticosteroid therapy, and serious infections. Mortality rates associated with serious infections were definitely higher in those patients who experienced any of the assessed risk factors at some time in their course. A patient profile that includes: (I) age less than ten years or greater than 40 years; (2) a cadaveric allograft, and (3) more than two rejection episodes with inherent high dose immunosuppressive therapy, increased the risk of serious infections and mortality. No attempt was made in this study to evaluate tissue typing and antigen matches of the cadaveric recipients with the risks analyzed since this information was not standardized throughout the time period studied. This data and data on patients who receive anti-lymphocytic globulin therapy may further delineate patients at greater risk for serious infections and unsuccessful outcomes.
